All articles tagged with #healthcare
President Trump is traveling to Walter Reed National Military Medical Center for routine annual dental and medical evaluations as part of preventive care, with a visit to meet service members and staff; officials say there are no serious health issues and he remains in excellent health as he nears age 80.
Florida is becoming a hub for aging research and longevity clinics, with University of Miami scientists studying brain-age and colon-polyp risk while University of Florida researchers explore how lifestyle can slow brain aging; clinics statewide offer screenings, peptides, and personalized plans that can cost from a few hundred to over $150,000 per year. At-home tests run about $200–$500 to estimate biological age, as researchers push toward brain-scan and AI-based biomarkers to better measure aging and guide interventions, though lifestyle factors remain a key determinant of biological age.
Seniors often receive tests and treatments that offer little benefit and can cause harm or waste, per USPSTF, the American Geriatrics Society, and Choosing Wisely. The article highlights seven examples (colonoscopies after 75, PSA testing after 70, mammograms after 75, Pap smears after 65, antibiotics for asymptomatic UTIs, removal of actinic keratoses, and long‑term levothyroxine for subclinical hypothyroidism) and urges patients to ask two questions before any test: what happens if we skip it, and is the benefit worth the risk at my age, while noting Medicare costs and the need for personalized decisions.
TriWest Healthcare Alliance apologized to more than 4 million TRICARE beneficiaries for errors in its patient portals that incorrectly showed they had Other Health Insurance, causing claim denials and delays amid the 2025 transition of TRICARE administration to TriWest. The move follows NBC News reporting of ongoing coverage problems and includes a case where a veteran’s cancer treatment was disrupted by denied claims. TriWest says OHI-related denials dropped from 2.3% to 1.3% and pledges further fixes, noting that testing before go-live faced unforeseen challenges acknowledged by the Defense Health Agency.
A BuzzFeed India piece compiles 35 anecdotes from medical professionals about the dumbest ER visits, often sparked by misread meds, odd beliefs, or outlandish self-diagnoses. The stories—from misinterpreting birth control effects to bizarre experiments and alcohol mishaps—show how fear, confusion, and simple misunderstandings drive people to emergency rooms, offering a mix of cringe-worthy humor and sobering lessons for patients and clinicians alike.
In the Democratic Republic of Congo, residents angry at the Ebola outbreak burned a treatment center, underscoring growing public frustration and complicating outbreak response by raising safety risks for healthcare workers and hindering containment efforts.
Eli Lilly announced topline TRIUMPH-1 results for retatrutide, a first-in-class GIP/GLP-1/glucagon triple agonist, in adults with obesity or overweight and comorbidities. Across 4 mg, 9 mg, and 12 mg doses, participants achieved meaningful weight loss at 80 weeks (4 mg: 19.0%, 9 mg: 25.9%, 12 mg: 28.3%), with the 12 mg group averaging 70.3 lb and 45.3% reaching ≥30% weight loss; BMI ≤22 was achieved by 65.3% at Week 80. Some participants with higher BMI continued losing weight in extensions, reaching about 30% total body weight loss over roughly two years. All arms met primary and key secondary endpoints, and the follow-on extension data covered up to 104 weeks. Safety disclosures mirror warnings associated with Lilly's obesity medicines.
President Trump announced an expansion of TrumpRx.gov to list more than 600 generic medications with transparent cash prices, enabling patients to compare the best cash prices at local pharmacies or delivery options against insurance co-pays, and integrating discounts from Amazon Pharmacy, Cost Plus Drugs, and GoodRx; the platform excludes controlled substances and meds not commonly offered direct-to-consumer, building on prior executive actions to lower US drug costs.
Greenland’s government condemned a US delegation that included a volunteer doctor, saying Greenlanders are not experimental subjects and warning against geopolitically driven meddling as talks over the island’s future continue and Greenland asserts its right to self-determination.
Merck announced TroFuse-005, a global Phase 3 trial, met its dual primary endpoints of overall survival and progression-free survival for sacituzumab tirumotecan (sac-TMT) versus physician’s choice chemotherapy in advanced or recurrent endometrial cancer after platinum-based therapy and anti‑PD-1/L1 therapy; interim analysis showed statistically significant OS and PFS improvements and a positive objective response rate, with a safety profile consistent with prior studies. The TroFuse program spans 17 global Phase 3 trials across multiple tumor types, highlighting Merck’s leadership in TROP2-directed ADCs in women’s cancers.
Regeneron disclosed a late-stage trial evaluating a Libtayo-based combination for melanoma failed to meet its endpoints when compared with Merck’s Keytruda, sparking investor scrutiny of Regeneron’s cancer-immunotherapy program.
Texas Children’s Hospital will launch what officials call the nation’s first detransition clinic for transgender youths as part of a settlement with the Texas attorney general and the U.S. justice department over alleged improper Medicaid billing and other claims related to gender-affirming care; the hospital will pay $10 million, terminate several physicians, and fund the detransition clinic for five years with services free to patients, while agreeing to stop providing puberty blockers, hormone therapy, or surgeries to minors. The deal is framed by Texas officials as a shift away from gender ideology, amid broader federal scrutiny of gender-affirming care for minors, with the DOJ saying it will continue pursuing enforcement against providers of such care.
A daughter is suing HaysMed and Dr. Roberto Cervera for $10 million after her father, Stephen Richter, died Oct. 1, 2024 during an aortic valve replacement at HaysMed. The suit claims negligence across multiple aspects of care, including evaluation, medical history, informed consent, management of cardioplegia, timing, and equipment readiness. Both sides deny wrongdoing; HaysMed has expressed sympathy but cannot comment due to pending litigation, and a venue-change request was denied. No hearing date has been set yet.
Regenxbio announced its experimental Duchenne muscular dystrophy gene therapy produced sufficient levels of a miniaturized muscle protein in a clinical trial, paving the way for an FDA submission and aiming to improve on Sarepta’s Elevidys in both efficacy and safety, amid ongoing safety concerns surrounding the competitor.
Filmmaker Adam McKay said on the Urgent Futures podcast that “no group is worse than white liberals” for America, blasting white liberal privilege and Democratic Party marketing while recounting his departure from the Democrats after Trump’s second term; he argues Democrats need policy and cultural reforms, including greater transparency around healthcare, and says there are numerous ways the party has harmed the public.